Page last updated: 2024-08-16

ribavirin and Behavior Disorders

ribavirin has been researched along with Behavior Disorders in 45 studies

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	29 (64.44)	29.6817
2010's	16 (35.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afdhal, NH; Curry, MP; Iriana, S	1
Beckstead, S; Beking, D; Finch, S; Knorr, T; Lynch, C; MacKenzie, M; Mayer, D; Melles, B; Newman, AI; Shore, R	1
Amano, K; Arinaga, T; Fujimoto, Y; Ide, T; Ishii, K; Kuhara, K; Kumashiro, R; Kuwahara, R; Miyajima, I; Morita, Y; Murashima, S; Ogata, K; Sakai, K; Sata, M; Shirachi, M; Uchimura, N	1
Chang, SC; Chung, YC; Hung, CT; Lee, HM; Li, SF; Pai, LW; Yang, SS	1
Gazdag, G; Horváth, G; Szabó, O; Takács, R; Ungvari, GS	1
Cabré Serres, M; Gorgas Torner, MQ; Parra Uribe, I; Pontes García, C; Rudi Sola, N; Vergara Gómez, M	1
Blunn, A; Chitturi, S; Farrell, G; Kaye, G; Rodrigo, K; Rodriguez-Morales, I; Shadbolt, B; Teoh, N; To, C; Wu, JY	1
Andreone, P; Gamal, N; Vukotic, R	1
Faus, MJ; Gallego, A; Guardiola, JM; Mangues, MA; Masip, M; Pagès, N; Torras, X; Tuneu, L	1
Elsheikh, E; Estep, JM; Gerber, L; Golabi, P; Karrar, A; Stepanova, M; Younossi, I; Younossi, ZM	1
Goto, H; Hayashi, K; Honda, T; Ishigami, M; Katano, Y; Nakano, I; Takamatsu, J; Toyoda, H; Yamamoto, K	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Katamura, Y; Kawamura, Y; Kobayashi, M; Kumada, H; Nomura, N; Saito, S; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H	1
Ghany, MG; Seeff, LB; Strader, DB; Thomas, DL	1
Freedman, K; Nathanson, J	1
Alvarez-Uria, G; Day, JN; Nasir, AJ; Russell, SK; Vilar, FJ	1
Folwaczny, C; Janssen, G; Loeschke, K; Lorenz, R; Martin, G; Schaefer, M; Schmidt, F; Soyka, M	1
Bishop, R; Cortez, KJ; Kottilil, S; Masur, H; McLaughlin, M; Murphy, A; Osinusi, A; Polis, MA; Proschan, M; Rasimas, JJ; Rosenstein, D	1
Cacoub, P; Chousterman, M; Fontanges, T; Lang, JP; Marcellin, P; Melin, P; Ouzan, D; Rotily, M	1
Casteelen, G; Coutinho, RA; Jansen, PL; Krol, A; Lambers, FA; Lindenburg, CE; Prins, M; Schinkel, J; Urbanus, AT; van den Berg, CH; van Santen, G; Weegink, CJ	1
Abbacchi, A; Adewuyi, SA; Debold, C; Hong, BA; Lisker-Melman, M; North, CS; Pollio, DE	1
Azuma, K; Dohmen, K; Furusyo, N; Hayashi, J; Kajiwara, E; Kotoh, K; Maruyama, T; Nakamuta, M; Nomura, H; Ogawa, E; Satoh, T; Shimoda, S; Takahashi, K; Tanabe, Y	1
Katsounas, A; Kottilil, S; Lempicki, RA; Masur, H; Murphy, AA; Osinusi, A; Polis, M; Rasimas, J; Raza, H; Rosenstein, D; Yang, J	1
Bourlière, M; Halfon, P; Portal, I	1
Gournay, J; Richou, C	1
Folwaczny, C; Grunze, H; Heldwein, W; Koenig, A; Loeschke, K; Lorenz, R; Martin, G; Schaefer, M; Schindlbeck, N; Schmidt, F; Soyka, M	1
Fried, MW; Russo, MW	1
Allen, S; Jacobs, G; Mitty, J; Schwartzapfel, B; Taylor, LE	1
Asnis, GM; De La Garza, R; Miller, AH; Raison, CL	1
Backmund, M; Heinz, A; Schaefer, M	1
Bozorg, B; Rifai, MA; Rosenstein, DL	1
Asnis, GM; De La Garza, R; Henderson, MA; Rego, SA; Reinus, JF	1
Ahmad, J; Anand, BS; Awad, J; Aytaman, A; Bini, EJ; Bräu, N; Chang, KM; Cheung, R; Currie, S; Hagedorn, C; Ho, SB; Hu, KQ; Jeffers, L; Johnson, D; King, P; Mendenhall, C; Morgan, TR; Moseley, R; Pedrosa, M; Rossi, S; Sasaki, AW; Schmidt, WN; Shen, H; Simon, F; Strader, D; Waters, B; Wright, TL	1
Sylvestre, DL	1
Hauser, P; Loftis, JM; Matthews, AM	1
Hauser, P; Loftis, JM; Rifai, MA	1
Bergin, C; Clarke, S; Farrell, G; Hennessy, M; Hopkins, S; Lambourne, J; McCullagh, L; Mulcahy, F	1
Arase, Y	1
Gorman, JM; Weiss, JJ	1
Ballesteros, AL; Clotet, B; Ferrer, MJ; Fumaz, CR; Fuster, D; Gómez, G; Masmitjà, E; Muñoz-Moreno, JA; Paredes, R; Pérez-Alvarez, N; Salas, A; Tural, C	1
De Heusden, N; Fischer, K; Mauser-Bunschoten, EP; Posthouwer, D	1
Dollarhide, AW; Endow-Eyer, R; Leckband, SG; Loh, C; Meyer, JM; Robinson, S	1
Berg, T; Friebe, A; Gutsche, J; Halangk, J; Heinz, A; Hinzpeter, A; Janssen, G; Kluschke, M; Mohmand, A; Pich, M; Sarkar, R; Schaefer, M; Schwaiger, M; Weich, V; Ziemer, M	1
Clements, BJ; Sylvestre, DL	1
Dougherty, KA; Evon, DM; Fried, MW; Galanko, JA; Simpson, K; Verma, A	1

Reviews

10 review(s) available for ribavirin and Behavior Disorders

Article	Year
Neurologic Manifestations of Hepatitis C Virus Infection. Clinics in liver disease, 2017, Volume: 21, Issue:3 Topics: Antiviral Agents; Cerebrovascular Disorders; Electroencephalography; Hepatitis C, Chronic; Humans; Interferons; Magnetic Resonance Imaging; Mental Disorders; Neurocognitive Disorders; Ribavirin	2017
Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders. Expert review of anti-infective therapy, 2009, Volume: 7, Issue:3 Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferons; Mental Disorders; Polyethylene Glycols; Ribavirin; Substance-Related Disorders; Treatment Outcome	2009
[Treatment of chronic hepatitis C in special groups]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Acute Disease; Adult; Antiviral Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Follow-Up Studies; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Transplantation; Liver Transplantation; Mental Disorders; Renal Dialysis; Ribavirin; Thalassemia; Time Factors	2002
Consensus conference. Treatment of hepatitis C. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Adult; Aged; Alcoholism; Amantadine; Antiviral Agents; Body Weight; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver Cirrhosis; Liver Transplantation; Male; Mental Disorders; Middle Aged; Monitoring, Physiologic; Quality of Life; Recurrence; Ribavirin; Risk Factors; Substance-Related Disorders; Time Factors	2002
[Treatment of chronic hepatitis C: side effects, tolerability and quality of life]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Anemia, Hemolytic; Antiviral Agents; Blood Cell Count; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Transplantation; Liver Transplantation; Mental Disorders; Neutropenia; Prospective Studies; Quality of Life; Retrospective Studies; Ribavirin; Risk Factors; Thrombocytopenia; Time Factors	2002
Side effects of therapy for chronic hepatitis C. Gastroenterology, 2003, Volume: 124, Issue:6 Topics: Antiviral Agents; Drug Therapy, Combination; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases; Mental Disorders; Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyroid Diseases	2003
Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction (Abingdon, England), 2004, Volume: 99, Issue:9 Topics: Antiviral Agents; Clinical Trials as Topic; Contraindications; Drug Therapy, Combination; Hepatitis C, Chronic; Heroin Dependence; Humans; Interferon-alpha; Mental Disorders; Research Design; Ribavirin; Substance-Related Disorders	2004
Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs, 2006, Volume: 66, Issue:2 Topics: Antiviral Agents; Comorbidity; Hepatitis C, Chronic; Humans; Interferons; Mental Disorders; Ribavirin; Substance-Related Disorders	2006
[Side effects of interferon therapy for chronic hepatitis C]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64, Issue:7 Topics: Antiviral Agents; Drug Therapy, Combination; Fatigue; Hepatitis C, Chronic; Humans; Interferons; Leukopenia; Mental Disorders; Ribavirin; Thrombocytopenia	2006
Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV. Current HIV/AIDS reports, 2006, Volume: 3, Issue:4 Topics: Antidepressive Agents; Antiviral Agents; Clinical Trials as Topic; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Mental Disorders; Patient Compliance; Polyethylene Glycols; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous	2006

Trials

8 trial(s) available for ribavirin and Behavior Disorders

Article	Year
Treatment of chronic hepatitis C infection among current and former injection drug users within a multidisciplinary treatment model at a community health centre. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2013, Volume: 27, Issue:4 Topics: Adult; Aged; Antiviral Agents; Community Health Centers; Community Health Services; Delivery of Health Care; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Ontario; Patient Care Team; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Treatment Outcome; Young Adult	2013
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:2 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Cardiovascular Diseases; Comorbidity; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Mental Disorders; Middle Aged; Patient Selection; Polyethylene Glycols; Prospective Studies; Ribavirin; Young Adult	2015
Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C. Alimentary pharmacology & therapeutics, 2009, Nov-15, Volume: 30, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Mental Disorders; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Ribavirin; Risk Factors; Severity of Illness Index; Time; Treatment Outcome; Young Adult	2009
HIV/Hepatitis C virus-coinfected virologic responders to pegylated interferon and ribavirin therapy more frequently incur interferon-related adverse events than nonresponders do. Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 53, Issue:3 Topics: Adult; Anemia; Antiviral Agents; Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Young Adult	2010
Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:7 Topics: Adult; Age Factors; Antiviral Agents; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Genotype; Hematologic Diseases; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Sex Factors	2012
Approaching treatment for hepatitis C virus infection in substance users. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jul-01, Volume: 41 Suppl 1 Topics: Adolescent; Adult; Disease Management; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2005
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:4 Topics: Adult; Antidepressive Agents; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Substance-Related Disorders; Treatment Outcome	2007
Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:9 Topics: Adult; Antiviral Agents; Diagnosis, Dual (Psychiatry); Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Heroin Dependence; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Methadone; Middle Aged; Patient Compliance; Prospective Studies; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2007

Other Studies

27 other study(ies) available for ribavirin and Behavior Disorders

Article	Year
The importance of a prior psychiatric examination in pegylated interferon and ribavirin combination treatment for chronic hepatitis C. The Kurume medical journal, 2012, Volume: 59, Issue:3-4 Topics: Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Mental Disorders; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome	2012
Risk of nonpsychotic mental disorders development in antiviral-treated mentally healthy chronic hepatitis C patients: A population-based study. Journal of the Formosan Medical Association = Taiwan yi zhi, 2015, Volume: 114, Issue:9 Topics: Adult; Antiviral Agents; Chi-Square Distribution; Databases, Factual; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Mental Disorders; Middle Aged; National Health Programs; Non-alcoholic Fatty Liver Disease; Psychiatric Status Rating Scales; Ribavirin; Risk Factors; Taiwan	2015
When do psychiatric side effects emerge during antiviral treatment of hepatitis C? Psychiatria Danubina, 2013, Volume: 25, Issue:4 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Mental Disorders; Middle Aged; Referral and Consultation; Retrospective Studies; Ribavirin; Time Factors	2013
[Multidisciplinary approach as a model for detection and monitoring of psychiatric morbidity in patients treated with interferon and ribavirin]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014, May-01, Volume: 38, Issue:3 Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Comorbidity; Drug Monitoring; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferons; Male; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Ribavirin	2014
Influence of psychiatric diagnosis on treatment uptake and interferon side effects in patients with hepatitis C. Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:6 Topics: Adult; Antiviral Agents; Depression; Disease Progression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Mental Disorders; Middle Aged; Multivariate Analysis; Ribavirin; Schizophrenia	2014
Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment. International journal of clinical pharmacy, 2015, Volume: 37, Issue:6 Topics: Adult; Age Factors; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Health Status; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Mental Disorders; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral; Severity of Illness Index; Sex Factors	2015
The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV). Medicine, 2016, Volume: 95, Issue:46 Topics: Affective Symptoms; Antiviral Agents; Benzimidazoles; Biomarkers; Cytokines; Female; Fluorenes; Hepatitis C, Chronic; Humans; Male; Mental Disorders; Middle Aged; Neurotransmitter Agents; Retrospective Studies; Ribavirin; Sofosbuvir	2016
Effect of ribavirin, in combination with interferon in patients with hepatitis C, on the bleeding risk associated with selective serotonin reuptake inhibitors. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:4 Topics: Antiviral Agents; Drug Therapy, Combination; Factor VII; Hemophilia A; Hemorrhage; Hepatitis C, Chronic; Humans; Interferon-alpha; Mental Disorders; Ribavirin; Risk Factors; Selective Serotonin Reuptake Inhibitors	2008
Natural human interferon beta plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus and a high viral load. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:21 Topics: Adult; Aged; Asian People; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-beta; Male; Mental Disorders; Middle Aged; Pilot Projects; Retrospective Studies; Ribavirin; Viral Load	2008
Diagnosis, management, and treatment of hepatitis C: an update. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:4 Topics: Biopsy; Counseling; Drug Users; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Mental Disorders; Polyethylene Glycols; Recombinant Proteins; Retreatment; Ribavirin; Treatment Failure	2009
Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection. Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:7 Topics: Adult; Antidepressive Agents; Antiviral Agents; Cohort Studies; Depression; Drug Therapy, Combination; Drug Users; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Mental Disorders; Middle Aged; Odds Ratio; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Treatment Failure; Viral Load	2009
Pegylated interferon-alpha2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort study. Antiviral therapy, 2010, Volume: 15, Issue:4 Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Female; France; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Mental Disorders; Middle Aged; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Treatment Outcome	2010
Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project. European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:1 Topics: Adult; Antibodies, Viral; Antiviral Agents; Cohort Studies; Comorbidity; Drug Users; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Netherlands; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Treatment Outcome	2011
The use of psychoeducation for a patient with hepatitis C and psychiatric illness in preparation for antiviral therapy: a case report and discussion. Journal of clinical psychology in medical settings, 2011, Volume: 18, Issue:1 Topics: Adaptation, Psychological; Alcoholism; Antiviral Agents; Awareness; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Patient Education as Topic; Problem Solving; Psychotherapy; Psychotherapy, Group; Recombinant Proteins; Recurrence; Ribavirin; Social Support; Substance Abuse, Intravenous; Suicidal Ideation	2011
Gene expression profiles predict emergence of psychiatric adverse events in HIV/HCV-coinfected patients on interferon-based HCV therapy. Journal of acquired immune deficiency syndromes (1999), 2012, Jul-01, Volume: 60, Issue:3 Topics: Adult; Antiviral Agents; Computational Biology; Down-Regulation; Female; Gene Expression Profiling; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Molecular Diagnostic Techniques; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Up-Regulation	2012
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:2 Topics: Adult; Alcohol Drinking; Antidepressive Agents; Antiviral Agents; Depression; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Medical Records; Mental Disorders; Methadone; Middle Aged; Patient Compliance; Patient Dropouts; Prospective Studies; Ribavirin; Risk Factors; Substance-Related Disorders	2003
Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Jun-01, Volume: 36, Issue:11 Topics: Anti-HIV Agents; Antiviral Agents; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Mental Disorders; Ribavirin; Substance-Related Disorders; Treatment Refusal; Viral Load	2003
Ribavirin may be an important factor in IFN-induced neuropsychiatric effects. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:4 Topics: Antiviral Agents; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Mental Disorders; Research Design; Ribavirin	2004
Interferon for hepatitis C patients with psychiatric disorders. The American journal of psychiatry, 2004, Volume: 161, Issue:12 Topics: Antiviral Agents; Bipolar Disorder; Comorbidity; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Mental Disorders; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Viral Load	2004
Interferon for hepatitis C patients with psychiatric disorders. The American journal of psychiatry, 2004, Volume: 161, Issue:12 Topics: Antiviral Agents; Bipolar Disorder; Comorbidity; Drug Therapy, Combination; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Mental Disorders; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Withdrawal Syndrome	2004
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. The American journal of gastroenterology, 2005, Volume: 100, Issue:8 Topics: Antiviral Agents; Contraindications; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Mental Disorders; Middle Aged; Patient Acceptance of Health Care; Patient Selection; Ribavirin; Substance-Related Disorders; Treatment Outcome; United States; Veterans	2005
Hepatitis C treatment of veterans with psychiatric illness. The American journal of gastroenterology, 2006, Volume: 101, Issue:3 Topics: Antiviral Agents; Cohort Studies; Comorbidity; Contraindications; Dementia; Hepatitis C, Chronic; Humans; Interferon-alpha; Mental Disorders; Prejudice; Ribavirin; Risk Factors; Substance-Related Disorders; Veterans	2006
Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals. HIV medicine, 2006, Volume: 7, Issue:4 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Blood Cell Count; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Carriers; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load	2006
Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients. AIDS care, 2007, Volume: 19, Issue:1 Topics: Adult; Antidepressive Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Polyethylene Glycols; Prospective Studies; Quality of Life; Recombinant Proteins; Recurrence; Ribavirin; Treatment Refusal	2007
Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience. Haemophilia : the official journal of the World Federation of Hemophilia, 2007, Volume: 13, Issue:1 Topics: Adolescent; Adult; Antiviral Agents; Blood Coagulation Disorders; Combined Modality Therapy; Depression; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load	2007
Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans. Journal of clinical gastroenterology, 2007, Volume: 41, Issue:3 Topics: Antiviral Agents; Comorbidity; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferons; Male; Mental Disorders; Middle Aged; Patient Compliance; Patient Selection; Retrospective Studies; Ribavirin; Veterans	2007
Psychiatric symptoms during interferon treatment for hepatitis C: experiences from a tertiary care hepatology centre. Alimentary pharmacology & therapeutics, 2008, Jun-01, Volume: 27, Issue:11 Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Psychotropic Drugs; Recombinant Proteins; Retrospective Studies; Ribavirin	2008